United States Pharmaceuticals

Assertio Therapeutics Inc (ASRT)

Track

Ticker: ASRT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 8 May 2020
Value US$4,651,927.15 | Price 305.76 | Shares 3,671 (+33.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-05-11 2020-05-08 PlS Planned sale
2.5
DAWES KAREN A
Non-Executive Director
3,671 +33.4%
305.76
US$4,651,927 		3,671 +33.4% 305.76 US$4,651,927
2019-11-12 2019-11-12 B Purchase HIGGINS ARTHUR J

Director, President and CEO

Executive Director
48,263 -45.4%
249.53
US$631,256 		48,263 -45.4% 249.53 US$631,256
2019-11-12 2019-11-11 B Purchase STAPLE PETER D Non-Executive Director
34,235 -41.7%
474.85
US$2,531,029 		34,235 -41.7% 474.85 US$2,531,029
2019-11-12 2019-11-11 B Purchase Peisert Daniel A.

SVP and CFO

Officer
10,000 +15.4%
0.73
US$7,259 		10,000 +15.4% 0.73 US$7,259
2019-08-20 2019-08-20 B Purchase Peisert Daniel A.

SVP and CFO

Officer
4,000 +7.6%
1.45
US$5,800 		4,000 +7.6% 1.45 US$5,800
2019-08-20 2019-08-20 B Purchase Peisert Daniel A.

SVP and CFO

Officer
10,000 +23.4%
1.52
US$15,200 		10,000 +23.4% 1.52 US$15,200
2019-08-20 2019-08-19 B Purchase HIGGINS ARTHUR J

Director, President and CEO

Executive Director
25,000 +16.7%
1.61
US$40,242 		25,000 +16.7% 1.61 US$40,242
2019-08-14 2019-08-13 B Purchase Bukofzer Stan

SVP, Chf Scitfc & Tech Officer

Officer
4,000 +17.4%
1.56
US$6,228 		4,000 +17.4% 1.56 US$6,228
2019-08-12 2019-08-12 B Purchase Peisert Daniel A.

SVP and CFO

Officer
17,100 +73.5%
1.57
US$26,847 		17,100 +73.5% 1.57 US$26,847
2019-08-12 2019-08-12 B Purchase Peisert Daniel A.

SVP and CFO

Officer
1,900 +8.9%
1.54
US$2,926 		1,900 +8.9% 1.54 US$2,926
2019-08-12 2019-08-12 B Purchase HIGGINS ARTHUR J

Director, President and CEO

Executive Director
50,000 +50.0%
1.54
US$76,900 		50,000 +50.0% 1.54 US$76,900
2019-06-14 2019-06-13 PlS Planned sale
2.5
DAWES KAREN A
12,500 -11.1%
3.18
US$39,794 		12,500 -11.1% 3.18 US$39,794
2019-05-09 2019-05-09 PlS Planned sale
MCKEE WILLIAM
Non-Executive Director
12,500 -15.6%
4.70
US$58,699 		12,500 -15.6% 4.70 US$58,699
2019-03-18 2019-03-14 B Purchase
3.3
Peisert Daniel A.

SVP and CFO

Officer
1,000 +4.9%
4.18
US$4,179 		1,000 +4.9% 4.18 US$4,179
2019-03-18 2019-03-14 B Purchase
3.3
Peisert Daniel A.

SVP and CFO

Officer
5,000 +32.6%
4.18
US$20,890 		5,000 +32.6% 4.18 US$20,890
2019-03-18 2019-03-14 B Purchase
3.1
HIGGINS ARTHUR J

Director, President and CEO

Executive Director
10,000 +11.1%
4.17
US$41,700 		10,000 +11.1% 4.17 US$41,700
2019-03-18 2019-03-14 B Purchase
Bukofzer Stan

SVP, Chf Scitfc & Tech Officer

Officer
5,000 +inf%
4.13
US$20,658 		5,000 +inf% 4.13 US$20,658
2018-12-17 2018-12-14 PlS Planned sale MCKEE WILLIAM Non-Executive Director
10,000 -51.3%
4.07
US$40,693 		10,000 -51.3% 4.07 US$40,693
2018-12-04 2018-12-03 S Sale DAWES KAREN A Non-Executive Director
8,421 -16.7%
4.84
US$40,725 		8,421 -16.7% 4.84 US$40,725
2018-05-15 2018-05-11 S Sale Gosling Matthew M

SVP, General Counsel

Officer
19,674 -100.0%
7.07
US$139,095 		19,674 -100.0% 7.07 US$139,095
2018-03-09 2018-03-07 S Sale Gosling Matthew M

SVP, General Counsel
45,519 -100.0%
6.58
US$299,515 		45,519 -100.0% 6.58 US$299,515
2017-12-15 2017-12-14 B Purchase HIGGINS ARTHUR J

President and CEO

Executive Director
75,000 +204.0%
8.16
US$612,000 		75,000 +204.0% 8.16 US$612,000
2017-06-15 2017-06-13 S Sale Vargas Thadd M

SVP, Business Development
160,820 -100.0%
9.53
US$1,531,971 		160,820 -100.0% 9.53 US$1,531,971
2017-06-15 2017-06-13 S Sale Vargas Thadd M

SVP, Business Development
19,816 -100.0%
9.60
US$190,234 		19,816 -100.0% 9.60 US$190,234
2017-06-15 2017-06-13 S Sale Vargas Thadd M

SVP, Business Development
21,751 -52.3%
9.59
US$208,527 		21,751 -52.3% 9.59 US$208,527
2017-06-13 2017-06-12 B Purchase HIGGINS ARTHUR J

President and CEO

Executive Director
15,000 +inf%
9.92
US$148,800 		15,000 +inf% 9.92 US$148,800
2017-05-15 2017-05-11 S Sale Vargas Thadd M

Senior VP, BD

Officer
50,000 -54.6%
12.03
US$601,250 		50,000 -54.6% 12.03 US$601,250
2017-05-15 2017-05-11 S Sale Gosling Matthew M

SVP, General Counsel

Officer
59,212 -74.1%
11.37
US$673,300 		59,212 -74.1% 11.37 US$673,300
2016-11-15 2016-11-14 PlS Planned sale Moretti August J

Chief Financial Officer & SVP

Officer
5,000 -18.7%
20.84
US$104,200 		5,000 -18.7% 20.84 US$104,200
2016-09-22 2016-09-21 PlS Planned sale Vargas Thadd M

Senior VP, BD

Officer
11,250 -13.3%
25.00
US$281,250 		11,250 -13.3% 25.00 US$281,250
2016-08-11 2016-08-10 PlS Planned sale Moretti August J

Chief Financial Officer & SVP

Officer
3,297 -13.2%
21.40
US$70,556 		3,297 -13.2% 21.40 US$70,556
2016-08-11 2016-08-10 PlS Planned sale Moretti August J

Chief Financial Officer & SVP

Officer
1,703 -7.3%
21.40
US$36,444 		1,703 -7.3% 21.40 US$36,444
2016-08-11 2016-08-10 PlS Planned sale Vargas Thadd M

Senior VP, BD

Officer
26,290 -23.8%
20.92
US$549,987 		26,290 -23.8% 20.92 US$549,987
2016-05-25 2016-05-23 PlS Planned sale Vargas Thadd M

Senior VP, BD

Officer
15,000 -12.1%
20.00
US$300,000 		15,000 -12.1% 20.00 US$300,000
2016-05-10 2016-05-10 PlS Planned sale Vargas Thadd M

Senior VP, BD

Officer
15,000 -10.8%
17.64
US$264,600 		15,000 -10.8% 17.64 US$264,600
2016-05-09 2016-05-09 PlS Planned sale Moretti August J

Chief Financial Officer & SVP

Officer
5,000 -17.9%
18.00
US$90,000 		5,000 -17.9% 18.00 US$90,000
2016-03-11 2016-03-11 S Sale Vargas Thadd M

Senior VP, BD

Officer
23,000 -14.3%
16.00
US$368,000 		23,000 -14.3% 16.00 US$368,000
2016-03-04 2016-03-02 S Sale Vargas Thadd M

SVP, Business Development

Officer
10,000 -5.9%
15.18
US$151,780 		10,000 -5.9% 15.18 US$151,780
2015-12-03 2015-12-03 PlS Planned sale Moretti August J

Chief Financial Officer & SVP

Officer
1,841 -7.9%
18.01
US$33,156 		1,841 -7.9% 18.01 US$33,156
2015-12-03 2015-12-03 PlS Planned sale Moretti August J

Chief Financial Officer & SVP

Officer
13,159 -36.2%
18.12
US$238,441 		13,159 -36.2% 18.12 US$238,441
2014-11-21 2014-11-19 PlS Planned sale Gosling Matthew M

Senior VP, General Counsel

Officer
71,000 -80.5%
15.36
US$1,090,347 		71,000 -80.5% 15.36 US$1,090,347
2014-03-14 2014-03-14 S Sale Vargas Thadd M

Senior VP, BD

Officer
63,869 -81.9%
14.69
US$938,210 		63,869 -81.9% 14.69 US$938,210
2014-03-14 2014-03-14 S Sale Gosling Matthew M

Senior VP, General Counsel

Officer
21,875 -65.7%
14.74
US$322,328 		21,875 -65.7% 14.74 US$322,328
2014-03-14 2014-03-14 S Sale Schoeneck James A

President and CEO

Executive Director
17,000 -14.6%
14.54
US$247,124 		17,000 -14.6% 14.54 US$247,124
2013-05-13 2013-05-10 B Purchase Schoeneck James A

President and CEO

Executive Director
25,000 +41.7%
5.11
US$127,632 		25,000 +41.7% 5.11 US$127,632
2013-03-06 2013-03-06 B Purchase DAWES KAREN A Non-Executive Director
2,000 +33.3%
5.96
US$11,920 		2,000 +33.3% 5.96 US$11,920
2012-12-14 2012-12-13 S Sale Sweeney Michael MD

CMO and VP, R&D

Officer
43,635 -96.3%
5.87
US$256,024 		43,635 -96.3% 5.87 US$256,024
2012-12-14 2012-12-12 PlS Planned sale Gosling Matthew M

Senior VP, General Counsel

Officer
65,702 -100.0%
5.84
US$383,851 		65,702 -100.0% 5.84 US$383,851
2012-08-15 2012-08-14 B Purchase STAPLE PETER D Non-Executive Director
4,700 +23.2%
5.01
US$23,547 		4,700 +23.2% 5.01 US$23,547
2012-08-15 2012-08-14 B Purchase STAPLE PETER D Non-Executive Director
300 +1.5%
5.01
US$1,502 		300 +1.5% 5.01 US$1,502
2011-09-12 2011-09-09 B Purchase STAPLE PETER D Non-Executive Director
1,500 +8.1%
5.71
US$8,565 		1,500 +8.1% 5.71 US$8,565
2011-09-12 2011-09-09 B Purchase STAPLE PETER D Non-Executive Director
500 +2.8%
5.70
US$2,850 		500 +2.8% 5.70 US$2,850
2011-09-12 2011-09-09 B Purchase STAPLE PETER D Non-Executive Director
1,500 +9.1%
5.68
US$8,520 		1,500 +9.1% 5.68 US$8,520
2011-09-12 2011-09-09 B Purchase STAPLE PETER D Non-Executive Director
1,400 +9.3%
5.67
US$7,938 		1,400 +9.3% 5.67 US$7,938
2011-09-12 2011-09-09 B Purchase STAPLE PETER D Non-Executive Director
100 +0.7%
5.66
US$566 		100 +0.7% 5.66 US$566
2011-08-24 2011-08-23 B Purchase Schoeneck James A

President and CEO

Executive Director
2,133 +11.9%
5.28
US$11,262 		2,133 +11.9% 5.28 US$11,262
2011-08-24 2011-08-23 B Purchase Schoeneck James A

President and CEO

Executive Director
2,000 +12.6%
5.27
US$10,540 		2,000 +12.6% 5.27 US$10,540
2011-08-24 2011-08-23 B Purchase Schoeneck James A

President and CEO

Executive Director
2,000 +14.4%
5.27
US$10,539 		2,000 +14.4% 5.27 US$10,539
2011-08-24 2011-08-23 B Purchase Schoeneck James A

President and CEO

Executive Director
2,000 +16.9%
5.16
US$10,320 		2,000 +16.9% 5.16 US$10,320
2011-08-24 2011-08-23 B Purchase Schoeneck James A

President and CEO

Executive Director
867 +7.9%
5.08
US$4,404 		867 +7.9% 5.08 US$4,404
2011-08-24 2011-08-23 B Purchase Schoeneck James A

President and CEO

Executive Director
2,000 +22.2%
5.04
US$10,080 		2,000 +22.2% 5.04 US$10,080
2011-08-24 2011-08-23 B Purchase Schoeneck James A

President and CEO

Executive Director
2,000 +28.6%
5.04
US$10,088 		2,000 +28.6% 5.04 US$10,088
2011-08-24 2011-08-23 B Purchase Schoeneck James A

President and CEO

Executive Director
2,000 +40.0%
5.05
US$10,098 		2,000 +40.0% 5.05 US$10,098
2011-08-24 2011-08-23 B Purchase Schoeneck James A

President and CEO

Executive Director
5,000 +inf%
5.05
US$25,250 		5,000 +inf% 5.05 US$25,250
2011-06-15 2011-06-15 PlS Planned sale Sweeney Michael MD

CMO and VP, R&D

Officer
1,385 -43.8%
8.40
US$11,627 		1,385 -43.8% 8.40 US$11,627
2011-06-15 2011-06-14 S Sale Cameron Tammy

VP, Finance

Officer
17,493 -81.5%
8.20
US$143,474 		17,493 -81.5% 8.20 US$143,474
2011-06-15 2011-06-14 S Sale Cameron Tammy

VP, Finance

Officer
4,487 -53.1%
8.20
US$36,801 		4,487 -53.1% 8.20 US$36,801
2011-06-15 2011-06-14 S Sale Cameron Tammy

VP, Finance

Officer
1,354 -25.5%
8.20
US$11,105 		1,354 -25.5% 8.20 US$11,105
2011-06-15 2011-06-14 B Purchase DAWES KAREN A Non-Executive Director
1,000 +20.0%
8.23
US$8,228 		1,000 +20.0% 8.23 US$8,228
2011-05-18 2011-05-16 B Purchase Zenoff David B Non-Executive Director
2,300 +13.3%
8.02
US$18,446 		2,300 +13.3% 8.02 US$18,446
2011-05-13 2011-05-13 B Purchase STAPLE PETER D Non-Executive Director
2,500 +20.0%
7.97
US$19,925 		2,500 +20.0% 7.97 US$19,925
2011-05-13 2011-05-13 S Sale BURRILL STEVEN Non-Executive Director
69,250 -63.4%
8.09
US$560,025 		69,250 -63.4% 8.09 US$560,025
2011-05-13 2011-05-12 S Sale Cameron Tammy

VP, Finance

Officer
18,821 -65.2%
8.26
US$155,367 		18,821 -65.2% 8.26 US$155,367
2011-05-13 2011-05-12 S Sale BURRILL STEVEN Non-Executive Director
87,000 -68.5%
8.25
US$717,750 		87,000 -68.5% 8.25 US$717,750
2011-05-13 2011-05-12 B Purchase STAPLE PETER D Non-Executive Director
2,500 +25.0%
8.30
US$20,750 		2,500 +25.0% 8.30 US$20,750
Explore more

More insider trading research around Assertio Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America